222 related articles for article (PubMed ID: 8505288)
41. Production of an expression system for a synaptobrevin fragment to monitor cleavage by botulinum neurotoxin B.
Nowakowski JL; Courtney BC; Bing QA; Adler M
J Protein Chem; 1998 Jul; 17(5):453-62. PubMed ID: 9717740
[TBL] [Abstract][Full Text] [Related]
42. Vesicle-associated membrane protein-2 (synaptobrevin-2) forms a complex with synaptophysin.
Washbourne P; Schiavo G; Montecucco C
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):721-4. PubMed ID: 7848269
[TBL] [Abstract][Full Text] [Related]
43. The C-terminal transmembrane region of synaptobrevin binds synaptophysin from adult synaptic vesicles.
Yelamanchili SV; Reisinger C; Becher A; Sikorra S; Bigalke H; Binz T; Ahnert-Hilger G
Eur J Cell Biol; 2005 Apr; 84(4):467-75. PubMed ID: 15900706
[TBL] [Abstract][Full Text] [Related]
44. High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity.
Anne C; Cornille F; Lenoir C; Roques BP
Anal Biochem; 2001 Apr; 291(2):253-61. PubMed ID: 11401299
[TBL] [Abstract][Full Text] [Related]
45. A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells.
Galli T; Zahraoui A; Vaidyanathan VV; Raposo G; Tian JM; Karin M; Niemann H; Louvard D
Mol Biol Cell; 1998 Jun; 9(6):1437-48. PubMed ID: 9614185
[TBL] [Abstract][Full Text] [Related]
46. Endocytosis of Clostridium botulinum type B neurotoxin into rat brain synaptosomes.
Kohda T; Kamata Y; Kozaki S
J Vet Med Sci; 2000 Nov; 62(11):1133-8. PubMed ID: 11129854
[TBL] [Abstract][Full Text] [Related]
47. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity.
Shone CC; Hambleton P; Melling J
Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784
[TBL] [Abstract][Full Text] [Related]
48. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.
Kozaki S; Kamata Y; Nishiki T; Kakinuma H; Maruyama H; Takahashi H; Karasawa T; Yamakawa K; Nakamura S
Infect Immun; 1998 Oct; 66(10):4811-6. PubMed ID: 9746583
[TBL] [Abstract][Full Text] [Related]
49. Calcium-dependent endogenous proteolysis of the vesicle proteins synaptobrevin and synaptotagmin.
Hausinger A; Volknandt W; Zimmermann H
Neuroreport; 1995 Mar; 6(4):637-41. PubMed ID: 7605916
[TBL] [Abstract][Full Text] [Related]
50. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
51. Active-site mutagenesis of tetanus neurotoxin implicates TYR-375 and GLU-271 in metalloproteolytic activity.
Rossetto O; Caccin P; Rigoni M; Tonello F; Bortoletto N; Stevens RC; Montecucco C
Toxicon; 2001 Aug; 39(8):1151-9. PubMed ID: 11306125
[TBL] [Abstract][Full Text] [Related]
52. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
Sikorra S; Henke T; Galli T; Binz T
J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
[TBL] [Abstract][Full Text] [Related]
53. A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity.
Adler M; Shafer HF; Manley HA; Hackley BE; Nicholson JD; Keller JE; Goodnough MC
J Protein Chem; 2003 Jul; 22(5):441-8. PubMed ID: 14690246
[TBL] [Abstract][Full Text] [Related]
54. Characterization of SNARE protein expression in beta cell lines and pancreatic islets.
Wheeler MB; Sheu L; Ghai M; Bouquillon A; Grondin G; Weller U; Beaudoin AR; Bennett MK; Trimble WS; Gaisano HY
Endocrinology; 1996 Apr; 137(4):1340-8. PubMed ID: 8625909
[TBL] [Abstract][Full Text] [Related]
55. Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain.
Cornille F; Goudreau N; Ficheux D; Niemann H; Roques BP
Eur J Biochem; 1994 May; 222(1):173-81. PubMed ID: 8200342
[TBL] [Abstract][Full Text] [Related]
56. Functional studies in 3T3L1 cells support a role for SNARE proteins in insulin stimulation of GLUT4 translocation.
Macaulay SL; Hewish DR; Gough KH; Stoichevska V; MacPherson SF; Jagadish M; Ward CW
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):217-24. PubMed ID: 9164859
[TBL] [Abstract][Full Text] [Related]
57. How botulinum and tetanus neurotoxins block neurotransmitter release.
Humeau Y; Doussau F; Grant NJ; Poulain B
Biochimie; 2000 May; 82(5):427-46. PubMed ID: 10865130
[TBL] [Abstract][Full Text] [Related]
58. Identification of a vesicle-associated membrane protein (VAMP)-like membrane protein in zymogen granules of the rat exocrine pancreas.
Braun JE; Fritz BA; Wong SM; Lowe AW
J Biol Chem; 1994 Feb; 269(7):5328-35. PubMed ID: 8106518
[TBL] [Abstract][Full Text] [Related]
59. Mechanism of action of tetanus and botulinum neurotoxins.
Montecucco C; Schiavo G
Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
[TBL] [Abstract][Full Text] [Related]
60. Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody.
Fabris F; Šoštarić P; Matak I; Binz T; Toffan A; Simonato M; Montecucco C; Pirazzini M; Rossetto O
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
